Novel blood‐based tumor mutation algorithm and nomogram predict survival of immune checkpoint inhibitor in non‐small‐cell lung cancer: Results from two multicenter, randomized clinical trials
2020 ◽
Vol 85
(4)
◽
pp. 761-771
◽
2019 ◽
Vol 14
(9)
◽
pp. 1608-1618
◽
2019 ◽